首页> 外文期刊>The journal of sexual medicine >Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors
【24h】

Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors

机译:使用合成的磷酸二酯酶5型抑制剂将声称的草药和自然性功能增强膳食补充剂掺假

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Many products labeled "herbal" or "all natural" (herbalatural) that claim to enhance sexual performance and imply use for the treatment of erectile dysfunction (ED) are marketed as over-the-counter (OTC) dietary supplements. However, adulteration with undeclared phosphodiesterase type 5 (PDE5) inhibitors appears widespread. Aim: To assess the availability, cost, origin, categorical content, and adulteration with PDE5 inhibitors of purported herbalatural OTC dietary supplements claiming to naturally enhance sexual performance. Methods: Pfizer Global Security coordinated sample collection (all from convenience stores and filling stations in two U.S. metropolitan areas except for seven from U.S. Customs seizures) and liquid chromatography/mass spectrometry examination. Main Outcome Measure: Adulteration with synthetic PDE5 inhibitors. Results: Ninety-one samples labeled as 58 distinct products and priced from $2.99 to $17.99 were evaluated. Origin/manufacture was claimed as United States (n=62), apparently Asian (n=15), and not clearly identified (n=14). Although no sample claimed to include synthetic substances, 74 (81%) contained PDE5-inhibitor pharmaceutical ingredients, including tadalafil and/or sildenafil (n=40, of which 18 contained >110% of the highest approved drug product strength) or PDE5-inhibitor analogs (n=34). Pronounced heterogeneity of contents between samples within individual products indicated minimal quality control during manufacture. Labeling was inadequate (e.g., lacking lot number and/or expiry date) for 17 products (23 samples) and inconsistent between samples within a given product (e.g., in manufacturer, lot number, and/or expiry date) for seven of 17 products having multiple samples. Only 14 samples warned against concomitant nitrate use. Conclusions: Ethical pharmaceutical companies are concerned for an unsuspecting public when their products are counterfeited, mislabeled, and illegally offered for sale in an unsafe manner. Because of the dangers of adulteration with synthetic PDE5 inhibitors, absent safety warnings, and lack of quality or consistent manufacture, men with ED unknowingly risk their health by using OTC herbalatural products that claim to enhance sexual performance.
机译:简介:许多标有“草本”或“纯天然”(草本/天然)标签的产品声称可增强性能力,并暗示可用于治疗勃起功能障碍(ED),是非处方(OTC)膳食补充剂。但是,掺入未声明的5型磷酸二酯酶(PDE5)抑制剂似乎很普遍。目的:评估声称声称天然增强性能力的草药/天然非处方药膳食补充剂的PDE5抑制剂的可用性,成本,来源,类别含量和掺假。方法:辉瑞全球安全部协调样品采集(所有样品从美国两个大城市的便利店和加油站进行采集,美国海关扣押的样品来自七个)和液相色谱/质谱检测。主要指标:掺入合成PDE5抑制剂。结果:评估了标记为58种不同产品,价格从2.99美元到17.99美元不等的91个样品。原产地/制造地被宣称为美国(n = 62),显然是亚洲人(n = 15),并且没有明确的标识(n = 14)。尽管没有样品声称含有合成物质,但其中74(81%)含有PDE5抑制剂药物成分,包括他达拉非和/或西地那非(n = 40,其中18种含量大于批准的最高药品强度的110%)或PDE5-抑制剂类似物(n = 34)。单个产品中样品之间内容物的明显异质性表明在制造过程中质量控制最小。 17种产品中的17种产品(23个样品)的标签不充分(例如,缺少批号和/或有效期限),并且给定产品内的样品之间的不一致(例如,制造商,批号和/或有效期限)有多个样本。只有14个样品警告不要同时使用硝酸盐。结论:当道德的制药公司的产品被假冒,贴错标签并且以不安全的方式非法出售时,道德制药公司会关注一个毫无戒心的公众。由于使用合成的PDE5抑制剂有掺假的危险,缺乏安全警告,缺乏质量或生产工艺不统一,患有ED的男性不知不觉地使用声称增强性能力的OTC草药/天然产品冒着健康风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号